tiprankstipranks
Evolent Health (EVH)
NYSE:EVH
US Market
EVH
Evolent Health
RESEARCH TOOLSreports
Want to see EVH full AI Analyst Report?

Evolent Health (EVH) Ratios

753 Followers

Evolent Health Ratios

EVH's free cash flow for Q2 2026 was $0.12. For the 2026 fiscal year, EVH's free cash flow was decreased by $ and operating cash flow was $-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.24 1.31 0.85 1.01 1.10
Quick Ratio
 1.24 1.31 0.85 1.01 1.10
Cash Ratio
 0.23 0.39 0.15 0.29 0.43
Solvency Ratio
 -0.24 -0.28 0.04 <0.01 0.07
Operating Cash Flow Ratio
 0.11 0.10 0.03 0.21 -0.03
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.11 0.00 0.00
Net Current Asset Value
$ -978.16M$ -977.67M$ -936.03M$ -928.93M$ -479.82M
Leverage Ratios
Debt-to-Assets Ratio
 0.49 0.52 0.28 0.24 0.26
Debt-to-Equity Ratio
 2.53 2.38 0.71 0.60 0.55
Debt-to-Capital Ratio
 0.72 0.70 0.42 0.38 0.36
Long-Term Debt-to-Capital Ratio
 0.72 0.70 0.33 0.36 0.32
Financial Leverage Ratio
 5.15 4.57 2.54 2.51 2.11
Debt Service Coverage Ratio
 -4.62 -6.28 0.44 1.19 5.59
Interest Coverage Ratio
 -0.41 -0.08 -1.64 -1.31 0.23
Debt to Market Cap
 2.10 2.12 0.51 0.16 0.16
Interest Debt Per Share
 9.24 9.17 6.44 6.28 5.25
Net Debt to EBITDA
 -2.70 -2.32 7.18 -18.24 6.58
Profitability Margins
Gross Profit Margin
12.92%15.14%14.38%23.45%23.42%
EBIT Margin
-20.64%-25.43%-1.50%-7.55%-3.44%
EBITDA Margin
-15.12%-19.26%3.32%-1.26%3.24%
Operating Profit Margin
-1.37%-0.24%-1.58%-3.63%0.27%
Pretax Profit Margin
-23.95%-28.50%-2.47%-10.31%-4.59%
Net Profit Margin
-24.08%-28.49%-2.41%-5.76%-1.42%
Continuous Operations Profit Margin
-24.08%-28.49%-2.41%-5.76%-1.38%
Net Income Per EBT
100.57%99.98%97.76%55.85%30.87%
EBT Per EBIT
1750.83%12054.93%155.70%284.23%-1704.48%
Return on Assets (ROA)
-25.61%-28.14%-2.42%-4.22%-1.05%
Return on Equity (ROE)
-99.16%-128.74%-6.15%-10.59%-2.23%
Return on Capital Employed (ROCE)
-1.94%-0.29%-2.21%-3.55%0.26%
Return on Invested Capital (ROIC)
-1.94%-0.29%-1.95%-1.97%0.08%
Return on Tangible Assets
-69.84%-86.24%-8.48%-13.93%-2.94%
Earnings Yield
-109.44%-117.00%-4.78%-3.08%-0.73%
Efficiency Ratios
Receivables Turnover
 4.67 5.80 6.16 4.40 5.31
Payables Turnover
 47.04 26.64 22.78 31.16 18.11
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 24.78 22.03 32.22 21.78 9.88
Asset Turnover
 1.06 0.99 1.00 0.73 0.74
Working Capital Turnover Ratio
 17.59 294.82 -51.64 72.68 21.97
Cash Conversion Cycle
 70.41 49.21 43.22 71.32 48.60
Days of Sales Outstanding
 78.17 62.91 59.25 83.03 68.76
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 7.76 13.70 16.02 11.71 20.15
Operating Cycle
 78.17 62.91 59.25 83.03 68.76
Cash Flow Ratios
Operating Cash Flow Per Share
 0.47 0.34 0.16 1.28 -0.12
Free Cash Flow Per Share
 0.15 0.04 -0.05 1.02 -0.53
CapEx Per Share
 0.32 0.30 0.22 0.26 0.41
Free Cash Flow to Operating Cash Flow
 0.32 0.12 -0.33 0.80 4.32
Dividend Paid and CapEx Coverage Ratio
 1.39 0.86 0.42 3.00 -0.30
Capital Expenditure Coverage Ratio
 1.47 1.14 0.75 4.96 -0.30
Operating Cash Flow Coverage Ratio
 0.05 0.04 0.03 0.22 -0.02
Operating Cash Flow to Sales Ratio
 0.03 0.02 <0.01 0.07 >-0.01
Free Cash Flow Yield
3.67%1.04%-0.47%3.10%-1.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.91 -0.79 -13.89 -32.51 -137.29
Price-to-Sales (P/S) Ratio
 0.22 0.24 0.51 1.87 1.95
Price-to-Book (P/B) Ratio
 1.20 1.10 1.29 3.44 3.06
Price-to-Free Cash Flow (P/FCF) Ratio
 27.21 96.07 -210.54 32.28 -52.71
Price-to-Operating Cash Flow Ratio
 8.65 11.76 68.75 25.77 -227.74
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 0.38 -0.06 3.09
Price-to-Fair Value
 1.20 1.10 1.29 3.44 3.06
Enterprise Value Multiple
 -4.15 -3.58 22.39 -166.50 66.73
Enterprise Value
 1.32B 1.29B 1.90B 4.13B 2.92B
EV to EBITDA
 -4.15 -3.58 22.39 -166.50 66.73
EV to Sales
 0.63 0.69 0.74 2.10 2.16
EV to Free Cash Flow
 77.64 272.28 -309.99 36.25 -58.48
EV to Operating Cash Flow
 24.67 33.33 101.23 28.94 -252.66
Tangible Book Value Per Share
 -7.69 -7.57 -7.12 -7.20 -3.27
Shareholders’ Equity Per Share
 3.41 3.64 8.73 9.60 9.17
Tax and Other Ratios
Effective Tax Rate
 >-0.01 <0.01 0.02 0.44 0.70
Revenue Per Share
 18.63 16.43 22.28 17.65 14.43
Net Income Per Share
 -4.49 -4.68 -0.54 -1.02 -0.20
Tax Burden
 1.01 1.00 0.98 0.56 0.31
Interest Burden
 1.16 1.12 1.65 1.37 1.33
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.02
SG&A to Revenue
 0.13 0.15 0.10 0.00 0.00
Stock-Based Compensation to Revenue
 0.02 0.02 0.02 0.02 0.03
Income Quality
 -0.10 -0.07 -0.30 -1.26 0.60
Currency in USD